IRIS
Moroni, Gabriella Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.116
NA - Nord America 1.609
SA - Sud America 821
EU - Europa 320
AF - Africa 58
OC - Oceania 7
Totale 4.931
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.511
SG - Singapore 1.322
BR - Brasile 708
CN - Cina 277
VN - Vietnam 219
HK - Hong Kong 95
IT - Italia 83
AR - Argentina 45
GB - Regno Unito 39
MX - Messico 39
CA - Canada 37
DE - Germania 30
ID - Indonesia 30
BD - Bangladesh 28
EC - Ecuador 27
IN - India 27
FI - Finlandia 25
IE - Irlanda 24
PL - Polonia 18
ZA - Sudafrica 18
AT - Austria 15
CO - Colombia 15
TR - Turchia 15
JP - Giappone 14
PK - Pakistan 14
IQ - Iraq 13
MA - Marocco 12
ES - Italia 11
SE - Svezia 11
UA - Ucraina 11
EG - Egitto 10
FR - Francia 10
NL - Olanda 10
RU - Federazione Russa 10
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CL - Cile 6
PY - Paraguay 6
SA - Arabia Saudita 6
CR - Costa Rica 5
MY - Malesia 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
JO - Giordania 4
KE - Kenya 4
LA - Repubblica Popolare Democratica del Laos 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
BB - Barbados 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
UY - Uruguay 3
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
GY - Guiana 2
KG - Kirghizistan 2
LT - Lituania 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
PW - Palau 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TO - Tonga 1
Totale 4.931
Salva come PNG Salva come JPEG
Città #
Singapore 449
The Dalles 440
Ashburn 178
Dallas 152
Shanghai 131
Hong Kong 95
Ho Chi Minh City 92
Beijing 85
New York 64
São Paulo 57
Hanoi 48
Boardman 43
Los Angeles 30
Wilmington 30
Mexico City 26
Helsinki 25
Naples 23
Dublin 22
Chandler 20
Rio de Janeiro 20
Warsaw 18
Brooklyn 16
Assago 14
Fort Worth 14
Montreal 14
Tokyo 14
Belo Horizonte 13
Boston 13
Curitiba 13
Santa Clara 13
Brasília 12
Johannesburg 12
Rome 12
Phoenix 11
Quito 11
Prineville 10
Salvador 10
San Mateo 10
Seattle 10
Buffalo 9
Campinas 9
Milan 9
San Francisco 9
Springfield 9
Stockholm 9
Vienna 9
Biên Hòa 8
Hải Dương 8
Nuremberg 8
Porto Alegre 7
Thái Bình 7
Baku 6
Can Tho 6
Da Nang 6
Denver 6
Guayaquil 6
Jakarta 6
Reston 6
Sorocaba 6
Atlanta 5
Baghdad 5
Bắc Ninh 5
Campos dos Goytacazes 5
Castro dei Volsci 5
Chicago 5
Dhaka 5
Hyderabad 5
Manaus 5
Piracicaba 5
Poplar 5
Vitória 5
Amman 4
Amsterdam 4
Ankara 4
Anápolis 4
Auckland 4
Buenos Aires 4
Cairo 4
Canoas 4
Chennai 4
Council Bluffs 4
Haiphong 4
Ipatinga 4
Jaraguá 4
Kuala Lumpur 4
Leawood 4
Maceió 4
Manchester 4
Nairobi 4
Nova Friburgo 4
Orem 4
Ottawa 4
Paris 4
Québec 4
Resistencia 4
Ribeirão Preto 4
San José 4
Santa Maria 4
São Vicente 4
Tashkent 4
Totale 2.595
Salva come PNG Salva come JPEG
Nome #
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review 101
De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis c (case study and literature review) 73
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 47
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology 47
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 46
Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis 45
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy (vol 29, pg 277, 2016) 45
Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up 45
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy? 43
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 43
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 43
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 41
Monoclonal gammopathy in lupus nephritis 40
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 39
Anti-glomerular basement membrane vasculitis 39
Acid-base balance and respiratory response during biofiltration with polyacrylonitrile membrane 39
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy 38
Anti-neutrophil cytoplasmic antibody-associated vasculitis in kidney transplantation 38
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis 38
ANCA-associated vasculitis with renal involvement 38
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden 38
Delayed Graft Function in Kidney Transplant: Risk Factors, Consequences and Prevention Strategies 38
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 36
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children 35
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 35
Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis 34
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 34
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 34
A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy 34
Old and new calcineurin inhibitors in lupus nephritis 34
Lupus nephritis: clinical presentations and outcomes in the 21st century 34
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: Clinico-pathological characterization and outcome 33
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 33
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 33
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus 32
''Nephritic flares'' are predictors of bad long-term renal outcome in lupus nephritis 32
Is preeclampsia a risk for end-stage renal disease? 32
C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis 32
Treatment of membranous lupus nephritis 32
Acute renal failure in a single kidney with previous obstruction 31
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis 31
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 31
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis 30
Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis 30
Lupus nephritis: When and how often to biopsy and what does it mean? 30
Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy 29
Acute post-bacterial glomerulonephritis in renal transplant patients: Description of three cases and review of the literature 29
Anti-C1Q monitoring predicts relapses of lupus nephritis 29
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 29
Autophagy: A Silent Protagonist in Kidney Transplantation 28
Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease 28
Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up 28
The risk of pregnancy in patients with lupus nephritis 28
Abnormalities of homocysteine and B vitamins in the nephrotic syndrome 28
Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? 28
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study 28
Is per-protocol kidney biopsy required in lupus nephritis? 27
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 27
The Impact of Preeclampsia in Lupus Nephritis 27
Alport syndrome and pregnancy: a case series and literature review 27
Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease 27
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 27
Predictors of renal survival in antineutrophil cytoplasmic antibody-associated vasculitis 27
Anti-C1q Autoantibodies in Lupus Nephritis 27
Membranoproliferative Glomerulonephritis Type I in Renal Transplantation Patients: A Single-Center Study of a Cohort of 68 Renal Transplants Followed Up for 11 Years 27
Renal biopsy in lupus nephritis - what for, when and how often? 27
The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival 27
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study 27
Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression 27
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 27
Remission and withdrawal of therapy in lupus nephritis 27
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients 27
Delayed Diagnosis of West Nile Virus Infection in a Kidney Transplant Patient Due to Inaccuracies in Commonly Available Diagnostic Tests 27
Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopathological classification schema and review of the literature 26
Renal replacement therapy in sarcoidosis 26
Kidney Involvement in Systemic Sclerosis 26
Pregnancy after lupus nephritis 26
Nephrotic syndrome: pathophysiology and consequences 26
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 26
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years 25
Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology 25
Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? 25
Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis 25
Neutrophil Extracellular Traps in the Autoimmunity Context 24
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 24
Lupus membranous nephropathy: long-term outcome 24
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 24
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update 24
The impact of recurrence of primary glomerulonephritis on renal allograft outcome 24
Cardiologic abnormalities in patients with long-term lupus nephritis 24
Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents 24
Renal sarcoidosis 24
When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review 24
Calcineurin Inhibitors in Membranous Nephropathy 23
Rituximab therapy for primary glomerulonephritis: Report on two cases 23
Treatment of dyslipidemia in kidney transplantation 23
Ribavirin as a beneficial treatment option for hepatitis C virusassociated glomerular disease 23
Urinary sediment features in proliferative and non-proliferative glomerular diseases 23
Low-dose rituximab is poorly effective in patients with primary membranous nephropathy 23
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 22
Totale 3.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 11 4 2 8 6 0 6
2021/202220 1 0 0 4 2 2 1 3 0 2 4 1
2022/202370 7 2 5 7 4 4 2 4 6 5 4 20
2023/2024267 33 12 47 20 14 41 33 10 4 2 17 34
2024/20252.222 12 97 65 14 17 237 138 173 267 604 294 304
2025/20262.548 827 395 336 686 224 80 0 0 0 0 0 0
Totale 5.167